Albert Bourla, Pfizer CEO (John Thys, Pool via AP Images)

How much? Pfiz­er ex­pects to reap at least $26B from Covid vac­cine in 2021

Pfiz­er’s Covid-19 vac­cine is like­ly to bring in about $26 bil­lion in 2021 rev­enues, which is more than $10 bil­lion more than the bio­phar­ma be­he­moth …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.